Carolinas Wealth Consulting’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,018
| Closed | -$70.7K | – | 638 |
|
|
2025
Q1 | $70.7K | Sell |
1,018
-74
| -7% | -$5.14K | 0.02% | 297 |
|
|
2024
Q4 | $93.9K | Buy |
1,092
+985
| +921% | +$84.7K | 0.02% | 260 |
|
|
2024
Q3 | $12.7K | Sell |
107
-1,000
| -90% | -$118K | ﹤0.01% | 531 |
|
|
2024
Q2 | $158K | Buy |
1,107
+1,049
| +1,809% | +$150K | 0.03% | 202 |
|
|
2024
Q1 | $7.51K | Buy |
58
+2
| +4% | +$259 | ﹤0.01% | 600 |
|
|
2023
Q4 | $5.84K | Hold |
56
| – | – | ﹤0.01% | 601 |
|
|
2023
Q3 | $5.45K | Hold |
56
| – | – | ﹤0.01% | 595 |
|
|
2023
Q2 | $4.6K | Buy |
+56
| New | +$4.6K | ﹤0.01% | 684 |
|
|
2020
Q4 | – | Sell |
-18
| Closed | -$1K | – | 980 |
|
|
2020
Q3 | $1K | Hold |
18
| – | – | ﹤0.01% | 862 |
|
|
2020
Q2 | $1K | Buy |
+18
| New | +$1K | ﹤0.01% | 598 |
|